YEXT INC (YEXT)

US98585N1063 - Common Stock

6.38  +0.02 (+0.31%)

After market: 6.38 0 (0%)

Fundamental Rating

3

YEXT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. YEXT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. YEXT is not valued too expensively and it also shows a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year YEXT was profitable.
YEXT had a positive operating cash flow in the past year.
YEXT had negative earnings in each of the past 5 years.
Of the past 5 years YEXT 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of YEXT (-3.51%) is comparable to the rest of the industry.
YEXT has a Return On Equity of -11.87%. This is comparable to the rest of the industry: YEXT outperforms 47.67% of its industry peers.
Industry RankSector Rank
ROA -3.51%
ROE -11.87%
ROIC N/A
ROA(3y)-9.38%
ROA(5y)-13.12%
ROE(3y)-32.43%
ROE(5y)-40.68%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 77.57%, YEXT is doing good in the industry, outperforming 73.48% of the companies in the same industry.
In the last couple of years the Gross Margin of YEXT has remained more or less at the same level.
YEXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y0.92%

4

2. Health

2.1 Basic Checks

YEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for YEXT has been increased compared to 1 year ago.
Compared to 5 years ago, YEXT has more shares outstanding
YEXT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

YEXT has an Altman-Z score of 0.02. This is a bad value and indicates that YEXT is not financially healthy and even has some risk of bankruptcy.
YEXT has a Altman-Z score of 0.02. This is in the lower half of the industry: YEXT underperforms 72.76% of its industry peers.
YEXT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.02
ROIC/WACCN/A
WACC11.78%

2.3 Liquidity

A Current Ratio of 0.86 indicates that YEXT may have some problems paying its short term obligations.
With a Current ratio value of 0.86, YEXT is not doing good in the industry: 79.57% of the companies in the same industry are doing better.
A Quick Ratio of 0.86 indicates that YEXT may have some problems paying its short term obligations.
YEXT's Quick ratio of 0.86 is on the low side compared to the rest of the industry. YEXT is outperformed by 79.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86

4

3. Growth

3.1 Past

YEXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1800.00%, which is quite impressive.
YEXT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.94%.
The Revenue has been growing by 12.11% on average over the past years. This is quite good.
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2551.46%
Revenue 1Y (TTM)0.94%
Revenue growth 3Y4.46%
Revenue growth 5Y12.11%
Sales Q2Q%12.68%

3.2 Future

Based on estimates for the next years, YEXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.33% on average per year.
The Revenue is expected to grow by 4.33% on average over the next years.
EPS Next Y7%
EPS Next 2Y28.74%
EPS Next 3Y15.23%
EPS Next 5Y16.33%
Revenue Next Year4.11%
Revenue Next 2Y6.72%
Revenue Next 3Y5.36%
Revenue Next 5Y4.33%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.76, YEXT is valued on the expensive side.
Based on the Price/Earnings ratio, YEXT is valued cheaper than 84.23% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, YEXT is valued a bit cheaper.
The Price/Forward Earnings ratio is 11.32, which indicates a very decent valuation of YEXT.
Based on the Price/Forward Earnings ratio, YEXT is valued cheaper than 92.83% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.73. YEXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.76
Fwd PE 11.32

4.2 Price Multiples

85.30% of the companies in the same industry are more expensive than YEXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.59
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as YEXT's earnings are expected to grow with 15.23% in the coming years.
PEG (NY)2.68
PEG (5Y)N/A
EPS Next 2Y28.74%
EPS Next 3Y15.23%

0

5. Dividend

5.1 Amount

YEXT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

YEXT INC

NYSE:YEXT (12/20/2024, 8:04:00 PM)

After market: 6.38 0 (0%)

6.38

+0.02 (+0.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners63.32%
Inst Owner Change2.02%
Ins Owners5.36%
Ins Owner Change-1.98%
Market Cap814.22M
Analysts80
Price Target7.21 (13.01%)
Short Float %2.41%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.75%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.82%
Min Revenue beat(4)-2.3%
Max Revenue beat(4)-1.28%
Revenue beat(8)0
Avg Revenue beat(8)-1.66%
Revenue beat(12)1
Avg Revenue beat(12)-1.54%
Revenue beat(16)4
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)2.46%
EPS NQ rev (1m)2.44%
EPS NQ rev (3m)2.44%
EPS NY rev (1m)-5.52%
EPS NY rev (3m)-3.6%
Revenue NQ rev (1m)8.83%
Revenue NQ rev (3m)8.83%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)6.36%
Valuation
Industry RankSector Rank
PE 18.76
Fwd PE 11.32
P/S 1.99
P/FCF 21.59
P/OCF 20.41
P/B 5.09
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.34
EY5.33%
EPS(NY)0.56
Fwd EY8.83%
FCF(TTM)0.3
FCFY4.63%
OCF(TTM)0.31
OCFY4.9%
SpS3.2
BVpS1.25
TBVpS-0.26
PEG (NY)2.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.51%
ROE -11.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.57%
FCFM 9.22%
ROA(3y)-9.38%
ROA(5y)-13.12%
ROE(3y)-32.43%
ROE(5y)-40.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y0.92%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 14.25%
Cap/Sales 0.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z 0.02
F-Score5
WACC11.78%
ROIC/WACCN/A
Cap/Depr(3y)44.15%
Cap/Depr(5y)178.69%
Cap/Sales(3y)1.88%
Cap/Sales(5y)5.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2551.46%
EPS Next Y7%
EPS Next 2Y28.74%
EPS Next 3Y15.23%
EPS Next 5Y16.33%
Revenue 1Y (TTM)0.94%
Revenue growth 3Y4.46%
Revenue growth 5Y12.11%
Sales Q2Q%12.68%
Revenue Next Year4.11%
Revenue Next 2Y6.72%
Revenue Next 3Y5.36%
Revenue Next 5Y4.33%
EBIT growth 1Y-49.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.45%
EBIT Next 3Y51.9%
EBIT Next 5Y29.13%
FCF growth 1Y728.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y261.28%
OCF growth 3Y237.56%
OCF growth 5Y54.52%